Delivery Order SPE2DB22D2211-SPE2DB24FPBA4
Award Date
8/1/24
Potential Completion Date
8/22/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product VYEPTI 100 mg/mL. The fixed-price contract, valued at $3,202.53, has an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department of Defense (DoD) and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a ceiling value of $9,607.59 and a period of performance ending on October 18, 2024. The award was made on September 26, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this contract,...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.72 firm fixed price contract is for the supply of VYEPTI 100 MG/ML VIALML, with a performance period ending on July 14, 2025. Amerisourcebergen Drug Corp is not a small business, as the contract is not set aside. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of VYEPTI 100 mg/mL injectable medication. The contract has a firm fixed-price of $6,405.06 and an ultimate completion date of October 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,337.55 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIAL, a specialty pharmaceutical product. The order has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The award does not have a set-aside designation. The potential value of the delivery order is $14,945.14, with a completion date of March 27, 2024. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The contract has a firm fixed price of $28,929.50 and a completion date of July 16, 2025. It is not a set-aside contract, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Vyepti 100 mg/mL vials, a specialty pharmaceutical medication. The contract has a ceiling value of $2,314.36 and a period of performance ending on June 13, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category....
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vyepti 100 mg/mL vials, a pharmaceutical product, with a ceiling value of $21,350.20 and a performance period through April 22, 2024. The contract is a firm fixed price delivery order, with no set-aside designation indicated. In addition to this specific delivery order, Amerisourcebergen...